Review Article
Prevention of Localized Osteitis in Mandibular Third-Molar Sites Using Platelet-Rich Fibrin
Table 2
Clinical data of patients who developed localized osteitis.
| Parameter | PRF | Non-PRF
| patients (n) | patients (n) |
| Age (yrs) ranges | | | 14–20 years | 0 | 6 | 21–25 years | 0 | 4 | 26–30 years | 0 | 1 | 31–35 years | 1 | 1 | 35–40 years | 0 | 0 | 40+ years | 1 | 1 | Females | 1 | 9 | Males | 1 | 4 | Oral contraceptive steroid users | 0 | 4 | Smokers/Oral Tobacco users | 0 | 1 | Diabetes (insulin dependent) | 1 | 1 | Estrogen therapy (HRT) | 1 | 0 | Patients receiving additional narcotic Rx’s | 2 | 9 | Patients receiving additional steroid Rx’s | 2 | 7 | Bilaterally occurring localized osteitis | 0 | 6 | PreOperative lower third molar eval | | | Partially bony impacted molar | 0 | 10 | Completely bony impacted molar | 2 | 9 |
|
|